← Back to headlines
MoonLake Immunotherapeutics Reports GAAP EPS of -$0.84
MoonLake Immunotherapeutics announced its GAAP Earnings Per Share (EPS) for the recent period, reporting a loss of $0.84 per share.
10 Aug, 11:12 — 10 Aug, 11:12
Sources
Showing 1 of 1 sources
